Tansy (Tanacetum vulgare)

Tansy (Tanacetum vulgare) contains volatile oils including thujone and camphor that may provide antioxidant activity. Traditional European folk medicine has used tansy for vermifugal and anti-inflammatory purposes, though clinical evidence remains limited.

Origin & History

Tansy (Tanacetum vulgare) is a perennial herbaceous flowering plant in the Asteraceae family, native to temperate Europe and Asia, commonly found wild-growing in Ukraine, CIS countries, Bulgaria, and Finland. It is sourced from aerial parts, particularly flowers and inflorescences, with essential oil extracted via steam distillation yielding 1.2% oil content.

Historical & Cultural Context

In traditional European medicine systems, particularly in Ukraine and CIS countries, tansy flowers have been historically used for vermifugal, choleretic, hepatoprotective, anti-inflammatory, analgesic, antimicrobial, and antipyretic effects. The herb has documented pharmacological features in traditional use but specific duration of historical application is not specified.

Health Benefits

• Traditional vermifugal (anti-parasitic) effects - based on historical use only, no clinical evidence
• Potential antioxidant activity - preliminary evidence shows ORAC value 605.4 ± 49.3 µmol TE/mL for essential oil
• Traditional anti-inflammatory properties - documented in European folk medicine, no clinical trials
• Hepatoprotective effects - traditional use only, no human studies available
• Antimicrobial activity - traditional application, lacking clinical validation

How It Works

Tansy's primary bioactive compounds include thujone, camphor, and borneol in its essential oil. The antioxidant activity appears mediated through free radical scavenging mechanisms, with measured ORAC values of 605.4 µmol TE/mL. Thujone may interact with GABA receptors and sodium channels, though this mechanism requires further validation.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for Tansy (Tanacetum vulgare) were found in the available research. The evidence base consists solely of chemical analysis of constituents and traditional use documentation.

Clinical Summary

Clinical research on tansy remains extremely limited with no human trials available. Laboratory studies have demonstrated antioxidant capacity with specific ORAC measurements for the essential oil. Traditional use documentation exists primarily from European ethnobotanical records rather than controlled studies. The vermifugal and anti-inflammatory claims are based solely on historical usage patterns without modern clinical validation.

Nutritional Profile

Tansy is not consumed as a food in meaningful quantities due to toxicity concerns, so standard macronutrient profiling (calories, protein, fat, carbohydrates, fiber) is not applicable in dietary contexts. Its relevance is phytochemical rather than nutritional. **Key bioactive compounds:** • **Thujone (α-thujone and β-thujone):** Major component of essential oil, typically 50–90% of oil composition depending on chemotype; α-thujone often 30–70%, β-thujone 5–30%. Thujone is a monoterpene ketone and the primary toxicological concern (convulsant, hepatotoxic at moderate doses). • **Camphor:** Present in many chemotypes at 5–30% of essential oil; some camphor-dominant chemotypes exist with camphor up to 40–60%. • **1,8-Cineole (eucalyptol):** 2–15% of essential oil depending on chemotype. • **Borneol and bornyl acetate:** Minor components, typically 1–8%. • **Chrysanthenyl acetate:** Reported in some chemotypes at 2–10%. • **Sesquiterpene lactones:** Including parthenolide (approximately 0.1–0.7% dry weight of aerial parts), tanacetin, and related germacranolides; these are considered responsible for anti-inflammatory and antiparasitic activity. • **Flavonoids:** Luteolin, apigenin, jaceosidin, eupatilin, and their glycosides; total flavonoid content approximately 1.5–3.5% dry weight of leaves. These contribute to antioxidant activity. • **Phenolic acids:** Chlorogenic acid, caffeic acid, isochlorogenic acids, and 3,5-dicaffeoylquinic acid; total phenolic content reported at approximately 45–85 mg GAE/g dry extract. • **Tannins:** Present in moderate amounts (~2–5% dry weight), contributing to astringent and antimicrobial properties. • **Vitamins and minerals:** No significant data available for micronutrient content; tansy is not a relevant dietary source of vitamins or minerals. • **Essential oil yield:** Typically 0.1–0.6% (v/w) from dried aerial parts by hydrodistillation. **Bioavailability notes:** Thujone is rapidly absorbed orally and crosses the blood-brain barrier, contributing to neurotoxicity risk. Sesquiterpene lactones such as parthenolide have limited oral bioavailability due to rapid metabolism, though lipophilic formulations may improve absorption. Flavonoid glycosides require intestinal hydrolysis for aglycone absorption; overall flavonoid bioavailability is estimated at 2–10%. The high chemotype variability across geographic populations means compound concentrations can differ dramatically between specimens.

Preparation & Dosage

No clinically studied dosage ranges are available for tansy extracts, powders, or standardized forms. No human studies have established safe or effective doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Wormwood, Black Walnut, Clove, Milk Thistle, Dandelion

Safety & Interactions

Tansy contains potentially toxic thujone compounds that can cause seizures, kidney damage, and liver toxicity in high doses. The herb is contraindicated during pregnancy and breastfeeding due to abortifacient properties and potential fetal harm. Tansy may interact with anticonvulsant medications due to thujone's effects on GABA receptors. Long-term use or high doses should be avoided due to cumulative toxicity risks from thujone accumulation.